Collaborators in the TBnet: Niklas Köhler (Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany; German Center for Infection Research (DZIF), TTU-TB, Borstel, Germany; Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany), Anca Vasiliu (Baylor College of Medicine, Department of Pediatrics, Global and Migrant Health, Global Tuberculosis Program, Houston, TX, USA), Ekkehardt Altpeter (Swiss Federal Office of Public Health, Division of Communicable Diseases, Bern, Switzerland), Tinna Rán Ægisdóttir (The National University Hospital of Iceland, Pharmaceutical Services, Reykjavik, Iceland), Marina Amerali (Tuberculosis Control Office, Dept of Respiratory Infections, Directorate for Epidemiological Surveillance and Intervention, National Public Health Organization (NPHO), Athens, Greece), Wouter Arrazola de Oñate (Belgian Lung and Tuberculosis Association, Brussels, Belgium; Flemish Association of Respiratory Health and TB Control, Leuven, Belgium), Ágnes Bakos (Koranyi National Institute for Pulmonology, Budapest, Hungary), Stefania D'Amato (Prevention of Communicable Diseases and International Prophylaxis, General Direction of Health Prevention, Ministry of Health of Italy, Rome, Italy), Daniela Maria Cirillo (IRCCS San Raffaele Scientific Institute, Milan, Italy), Reinout van Crevel (Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK), Edita Davidaviciene (Vilnius University Hospital Santaros Klinikos, Department of Tuberculosis State Information System, Vilnius, Lithuania), Irène Demuth (Health Directorate of Luxembourg, Luxembourg), Jose Domínguez (Institut d'Investigació Germans Trias i Pujol; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias; INNOVA4TB consortium, Badalona, Barcelona, Spain), Raquel Duarte (ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; ISPUP – Instituto de Saúde Pública da Universidade do Porto; Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto, Portugal), Gunar Günther (Department of Pulmonary Medicine and Allergology, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia), Jean-Paul Guthmann (Division of Infectious Diseases, Santé publique France, Saint-Maurice, France), Sophia Hatzianastasiou (Tuberculosis Control Office, Dept of Respiratory Infections Directorate for Epidemiological Surveillance and Intervention, National Public Health Organization (NPHO), Athens, Greece), Louise Hedevang Holm (Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark), Zaida Herrador Ortiz (National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain), Urška Hribar (Tuberculosis Register of the Republic of Slovenia, University Clinic Golnik, Golnik, Slovenia), Conny Huberty (Health Directorate of Luxembourg, Luxembourg), Elmira Ibraim (Marius Nasta Institute of Pulmonology, Bucharest, Romania), Sarah Jackson (Infectious Diseases, Health Service Executive – Health Protection Surveillance Centre, Dublin, Ireland), Mogens Jensenius (Department of Infectious Diseases, Oslo University Hospital, Ullevaal, Norway), Kamilla Sigridur Josefsdottir (Centre for Health Security and Communicable Disease Control, Directorate of Health, Iceland), Anders Koch (Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark), Maria Korzeniewska-Kosela (Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland), Liga Kuksa (Riga East University Hospital, TB and Lung Disease Clinic, Riga, Latvia), Heinke Kunst (Blizard Institute, The London School of Medicine and Dentistry, Queen Mary University of London, London, UK), Christian Lienhardt (Unité Unité Mixte Internationale 233 IRD – U1175 INSERM – Université de Montpellier, Institut de Recherche pour le Développement (IRD), Montpellier, France; Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK), Beatrice Mahler (Department Pneumology I, Marius Nasta Institute of Pneumology, Bucharest, Romania; Department Cardio-thoracic, Pneumophtisiology II, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania), Mateja Janković Makek (University of Zagreb, School of Medicine Zagreb, Croatia; University Hospital Centre Zagreb, Department for Lung diseases, Zagreb, Croatia), Paul McKeown (Health Protection Surveillance Centre, Gastrozoonotic and Vectorborne Diseases Division, Dublin, Ireland), Inge Muylle (Division of Pneumology, Onze-Lieve-Vrouw Ziekenhuis (OLV) Aalst, Aalst, Belgium), Johan Normark (Department of Clinical Microbiology, Umeå University, Sweden; Wallenberg Centre for Molecular Medicine, Umeå University, Sweden), Analita Pace-Asciak (Infectious Disease Prevention and Control Unit, Health Promotion and Disease Prevention Directorate, Superintendence of Public Health, Ministry for Health of Malta, La Valetta, Malta), Goranka Petrović (Respiratory Diseases and Travel Medicine Department with Vaccination Unit, Infectious Diseases Epidemiology Service Department, Croatian Institute of Public Health, Zagreb, Croatia), Despo Pieridou (Cyprus National Reference Laboratory for Mycobacteria, Microbiology Department, Nicosia General Hospital, Nicosia, Cyprus), Giulia Russo (Emerging Bacterial Pathogens Unit, DITID-IRCCS Ospedale San Raffaele, Milan, Italy), Olena Rzhepishevska (Department of Chemistry, Department of Clinical Microbiology, Umeå University, Sweden), Helmut J.F. Salzer (Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4/Pneumology, Kepler University Hospital and Faculty of Medicine, Johannes Kepler University, Linz, Austria; Ignaz-Semmelweis-Institute, Interuniversity Institute for Infection Research, Vienna, Austria), Marta Sá Marques (Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal), Daniela Schmid (Unit for Infectious Diseases Diagnostics and Infectious Diseases Epidemiology, Centre for Pathophysiology, Infectious Diseases and Immunology, Medical University of Vienna, Vienna, Austria), Ivan Solovic (National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy; Catholic University Ruzomberok, Ruzomberok, Slovakia), Mariya Sukholytka (First Faculty of Medicine and Faculty Thomayer Hospital Prague, Czech Republic), Petra Svetina (National TB Program and Tuberculosis Registry of Republic of Slovenia, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia), Mariya Tyufekchieva (Health Promotion and Prevention Unit, Directorate Public Health Protection and Health Control, Ministry of Health of Bulgaria, Sofia, Bulgaria), Tuula Vasankari (University of Turku, Division of Medicine, Department of Pulmonary Diseases and Clinical Allergology, Turku, Finland; Finnish Lung Health Association (Filha ry), Helsinki, Finland), Piret Viiklepp (Estonian Tuberculosis Register, Dept of Registries, National Institute for Health Development, Tallinn, Estonia), Kersti Villand (Estonian Tuberculosis Register, Dept of Registries, National Institute for Health Development, Tallinn, Estonia), Jiri Wallenfels (National TB Surveillance Unit, University Hospital Bulovka, Prague, Czech Republic), Stefan Wesolowski (National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland), Anna Maria Mandalakas (Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA; Research Center Borstel, Clinical Infectious Diseases, Borstel, Germany), Leonardo Martinez (Boston University, School of Public Health, Department of Epidemiology, Boston, MA, USA), Dominik Zenner (Global Public Health Unit, Wolfson Institute of Population Health Barts, The London School of Medicine and Dentistry, Queen Mary University of London, London, UK), Christoph Lange (Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany; German Center for Infection Research (DZIF), TTU-TB, Borstel, Germany; Respiratory Medicine and International Health, University of Lübeck, Germany; Baylor College of Medicine and Texas Childreńs Hospital, Houston, TX, USA).